{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:36:36Z","timestamp":1788690996282,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,6]]},"abstract":"<jats:sec>\n                    <jats:title>Purpose of review<\/jats:title>\n                    <jats:p>To summarize current literature describing the respiratory complications of neuromuscular disease (NMD) and the effect of respiratory interventions and to explore new gene therapies for patients with NMD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent findings<\/jats:title>\n                    <jats:p>Measurements of respiratory function focus on vital capacity and maximal inspiratory and expiratory pressure and show decline over time. Management of respiratory complications includes lung volume recruitment, mechanical insufflation-exsufflation, chest physiotherapy and assisted ventilation. Lung volume recruitment can slow the progression of lung restriction. New gene-specific therapies for Duchenne muscular dystrophy and spinal muscular atrophy have the potential to preserve respiratory function longitudinally. However, the long-term therapeutic benefit remains unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>Although NMDs are heterogeneous, many lead to progressive muscle weakness that compromises the function of the respiratory system including upper airway tone, cough and secretion clearance and chest wall support. Respiratory therapies augment or support the normal function of these components of the respiratory system. From a respiratory perspective, the new mutation and gene-specific therapies for NMD are likely to confer long-term therapeutic benefit. More sensitive and standard tools to assess respiratory function longitudinally are needed to monitor respiratory complications in children with NMD, particularly the youngest patients.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/mop.0000000000000498","type":"journal-article","created":{"date-parts":[[2017,3,24]],"date-time":"2017-03-24T01:41:38Z","timestamp":1490319698000},"page":"326-333","source":"Crossref","is-referenced-by-count":24,"title":["Respiratory complications, management and treatments for neuromuscular disease in children"],"prefix":"10.1097","volume":"29","author":[{"given":"MyMy C.","family":"Buu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20230918","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.paed.2015.06.011","article-title":"Management of respiratory disease in children with muscular weakness","volume":"25","author":"Abusamra","year":"2015","journal-title":"Paediatr Child Health"},{"issue":"(Suppl 1)","key":"R2-20230918","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2012-201964","article-title":"British thoracic society guideline for respiratory management of children with neuromuscular weakness","volume":"67","author":"Hull","year":"2012","journal-title":"Thorax"},{"key":"R3-20230918","doi-asserted-by":"crossref","first-page":"e0151445","DOI":"10.1371\/journal.pone.0151445","article-title":"Timed rise from floor as a predictor of disease progression in Duchene muscular dystrophy: An observational study","volume":"11","author":"Mazzone","year":"2016","journal-title":"PLoS One"},{"key":"R4-20230918","first-page":"149","article-title":"The Northstar Ambulatory Assessment in Duchene muscular dystrophy: considerations for the design of clinical trials","volume":"87","author":"Ricotti","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"R5-20230918","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/ppul.23172","article-title":"Characterization of pulmonary function in Duchene muscular dystrophy","volume":"50","author":"Mayer","year":"2015","journal-title":"Pediatr Pulmonol"},{"key":"R6-20230918","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/mus.24899","article-title":"Respiratory motor function in individuals with centronuclear myopathies","volume":"53","author":"Smith","year":"2016","journal-title":"Muscle Nerve"},{"key":"R7-20230918","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.resp.2015.11.013","article-title":"Altered activation of the diaphragm in late-onset pompe disease","volume":"222","author":"Smith","year":"2016","journal-title":"Respir Physiol Neurobiol"},{"key":"R8-20230918","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1136\/jmedgenet-2015-103387","article-title":"The importance of genetic diagnosis for Duchene muscular dystrophy","volume":"53","author":"Aartsma-Rus","year":"2016","journal-title":"J Med Genet"},{"key":"R9-20230918","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jamaneurol.2015.3537","article-title":"Identifying non-Duchene muscular dystrophy-positive and false negative results in prior Duchene muscular dystrophy newborn screening programs: a review","volume":"73","author":"Gatheridge","year":"2016","journal-title":"JAMA Neurol"},{"key":"R10-20230918","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1513\/AnnalsATS.201507-475BC","article-title":"Long-term effects of lung volume recruitment on maximal inspiratory capacity and vital capacity in Duchene muscular dystrophy","volume":"13","author":"Katz","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R11-20230918","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13023-015-0267-0","article-title":"Use of mechanical airway clearance devices in the home by people with neuromuscular disorders: effects on health service use and lifestyle benefits","volume":"10","author":"Mahede","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"R12-20230918","doi-asserted-by":"crossref","first-page":"477","DOI":"10.4187\/respcare.03584","article-title":"Efficacy of mechanical insufflation-exsufflation in extubating unweanable subjects with restrictive pulmonary disorders","volume":"60","author":"Bach","year":"2015","journal-title":"Respir Care"},{"key":"R13-20230918","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1513\/AnnalsATS.201509-597OC","article-title":"The impact of high-frequency chest wall oscillation on healthcare use in patients with neuromuscular diseases","volume":"13","author":"Lechtzin","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R14-20230918","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5535\/arm.2016.40.1.74","article-title":"Comparison of pulmonary functions at onset of ventilatory insufficiency in patients with amyotrophic lateral sclerosis, Duchene muscular dystrophy, and myotonic muscular dystrophy","volume":"40","author":"Cho","year":"2016","journal-title":"Ann Rehabil Med"},{"key":"R15-20230918","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/ppul.23229","article-title":"A comparison of invasive and noninvasive ventilation in children less than 1 year of age: a long-term follow-up study","volume":"51","author":"Kherani","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"R16-20230918","doi-asserted-by":"crossref","first-page":"462","DOI":"10.4187\/respcare.04217","article-title":"Ventilator settings to avoid nuisance alarms during mouthpiece ventilation","volume":"61","author":"Carlucci","year":"2016","journal-title":"Respir Care"},{"key":"R17-20230918","first-page":"CD005375","article-title":"Surgery for scoliosis in Duchene muscular dystrophy","volume":"10","author":"Cheuk","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"R18-20230918","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/BPO.0000000000000396","article-title":"Long-term follow-up of pulmonary function and scoliosis in patients with Duchene's muscular dystrophy and spinal muscular atrophy","volume":"36","author":"Chua","year":"2016","journal-title":"J Pediatr Orthoped"},{"key":"R19-20230918","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1212\/WNL.0000000000001416","article-title":"Evidence-based guideline summary: evaluation, diagnosis, and management of congenital muscular dystrophy \u2013 report of the guideline development subcommittee of the american academy of neurology and the practice issues review panel of the American Association of Neuromuscular & Electrodiagnostic Medicine","volume":"84","author":"Kang","year":"2015","journal-title":"Neurology"},{"key":"R20-20230918","doi-asserted-by":"crossref","first-page":"e16","DOI":"10.1164\/rccm.201602-0276ST","article-title":"An official American Thoracic Society Clinical Practice Guideline: pediatric chronic home invasive ventilation","volume":"193","author":"Sterni","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"R21-20230918","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1513\/AnnalsATS.201603-196CME","article-title":"Pediatric chronic home invasive ventilation","volume":"13","author":"Moore","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"R22-20230918","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1164\/rccm.200307-885ST","article-title":"Respiratory care of the patient with Duchene muscular dystrophy: ATS consensus statement","volume":"170","author":"Finder","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"R23-20230918","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S1474-4422(09)70271-6","article-title":"Diagnosis and management of Duchene muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"R24-20230918","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S1474-4422(09)70272-8","article-title":"Diagnosis and management of Duchene muscular dystrophy, part 2: implementation of multidisciplinary care","volume":"9","author":"Bushby","year":"2010","journal-title":"Lancet Neurol"},{"key":"R25-20230918","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.4187\/respcare.04676","article-title":"Respiratory care received by individuals with Duchene muscular dystrophy from 2000 to 2011","volume":"61","author":"Andrews","year":"2016","journal-title":"Respir Care"},{"key":"R26-20230918","article-title":"Adherence and barriers to hyperinsufflation in children with congenital muscular dystrophy","author":"Pascoe","year":"2016","journal-title":"Pediatr Pulmonol"},{"key":"R27-20230918","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/ana.23982","article-title":"Eteplirsen for the treatment of Duchene muscular dystrophy","volume":"74","author":"Mendell","year":"2013","journal-title":"Ann Neurol"},{"key":"R28-20230918","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/ana.24555","article-title":"Longitudinal effect of eteplirsen versus historical control on ambulation in Duchene muscular dystrophy","volume":"79","author":"Mendell","year":"2016","journal-title":"Ann Neurol"},{"key":"R29-20230918","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0000000000002445","article-title":"Results from a phase 1 study of nusinersen (isis-smn(rx)) in children with spinal muscular atrophy","volume":"86","author":"Chiriboga","year":"2016","journal-title":"Neurology"},{"key":"R30-20230918","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1016\/S0140-6736(16)31408-8","article-title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: a phase 2, open-label, dose-escalation study","volume":"388","author":"Finkel","year":"2016","journal-title":"Lancet"},{"key":"R31-20230918","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0909825","article-title":"Effect of vx-770 in persons with cystic fibrosis and the g551d-cftr mutation","volume":"363","author":"Accurso","year":"2010","journal-title":"N Engl J Med"},{"key":"R32-20230918","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/MCP.0000000000000211","article-title":"The future of CFTR modulating therapies for cystic fibrosis","volume":"21","author":"Davies","year":"2015","journal-title":"Curr Opin Pulm Med"}],"container-title":["Current Opinion in Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00008480-201706000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:14:10Z","timestamp":1786047250000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00008480-201706000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mop.0000000000000498","relation":{},"ISSN":["1040-8703","1531-698X"],"issn-type":[{"value":"1040-8703","type":"print"},{"value":"1531-698X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,6]]}}}